← Back to Clinical Trials
Recruiting NCT07417865

ECHO Diabetes FQHC

Trial Parameters

Condition Diabetes
Sponsor University of Florida
Study Type OBSERVATIONAL
Phase N/A
Enrollment 18
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-01-22
Completion 2028-07-31
Interventions
ECHO Diabetes tele-education

Brief Summary

Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twice monthly tele-education sessions delivered by UF's "hub" team in a 6-month program. The program will be evaluated using pre/posttest provider-level surveys and center-level aggregate data in a stepped-wedge trial design with 3 cohorts of FQHCs. The primary outcomes are the proportion of people \>9% HbA1c and technology use (CGM and insulin pump).

Eligibility Criteria

Inclusion Criteria: Federally Qualified Health centers (spokes) are eligible to participate that are part of Health Choice Network (HCN) or Alliance Chicago (AC). All people living with diabetes 18 and older are included in aggregate data sharing to evaluate outcomes. \- Exclusion Criteria: * Non FQHC, not part of HCN or AC

Related Trials